Open AccessFactors associated with remaining on initial randomized efavirenz-containing regimens
Author(s) -
Marlene Smurzynski,
Kun Wu,
Jeffrey T. Schouten,
Judith J. Lok,
Ronald J. Bosch,
Babafemi Taiwo,
Victoria A. Johnson,
Ann C. Collier
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328361645f
Subject(s) - efavirenz , medicine , odds ratio , regimen , logistic regression , cohort , didanosine , human immunodeficiency virus (hiv) , viral load , immunology , antiretroviral therapy
Efavirenz (EFV) along with two nucleoside reverse transcriptase inhibitors (NRTIs) is a recommended initial antiretroviral regimen. Understanding characteristics related to EFV success is clinically useful.